Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (6): 1134-1140. doi: 10.19723/j.issn.1671-167X.2022.06.013

Previous Articles     Next Articles

Diagnostic values of urinary citrate for kidney stones in patients with primary gout

Yu WANG1,Hui-min ZHANG2,Xue-rong DENG1,Wei-wei LIU3,Lu CHEN4,Ning ZHAO5,Xiao-hui ZHANG1,Zhi-bo SONG1,Yan GENG1,Lan-lan JI1,Yu WANG2,Zhuo-li ZHANG1,*()   

  1. 1. Department of Rheumatology and Immunology, Peking University First Hospital, Beijing 100034, China
    2. Department of Nephrology, Peking University First Hospital, Beijing 100034, China
    3. Department of Internal General Medicine, Zhongjie Hospital, Cangzhou 061108, Hebei, China
    4. Department of Traditional Chinese Medicine, Aviation General Hospital of China Medical University, Beijing 100012, China
    5. Department of Acupuncture, Huguosi Traditional Chinese Medicine Hospital affiliated to Beijing University of Chinese Medicine, Beijing 100035, China
  • Received:2022-08-10 Online:2022-12-18 Published:2022-12-19
  • Contact: Zhuo-li ZHANG E-mail:zhuoli.zhang@126.com
  • Supported by:
    National Natural Science Foundation of China(81501400);National High Level Hospital Clinical Research Funding(Interdepartmental Clinical Research Project of Peking University First Hospital)(2022CR10)

RICH HTML

   

PDF (PC)

Abstract:

Objective: To evaluate the relationship between 24 h urinary ion content and kidney stones, and to explore the diagnostic values of kidney stone in primary gout patients. Methods: Patients diagnosed with primary gout had ultrasound scanning of both feet and kidneys in Peking University First Hospital from Jan. 2020 to May 2021. Their clinical characteristics were compared between the positive and negative kidney stone groups, and the relationship between kidney stone and urinary ion composition were analyzed. Risk factors of kidney stone were analyzed. The explored diagnostic values were evaluated for urinary oxalate and citrate according with uric acid kidney stones by dual-energy computed tomography (DECT). Results: Among the 100 gouty patients, 80 patients had uric acid crystal deposition in lower joints of extremity by ultrasonography, 61 patients had kidney stone, and 34 had kidney uric acid stones by DECT. All the multiple kidney stones were proved as uric acid kidney stones by DECT. Compared with patients without kidney stone group proved by ultrasonography, patients with kidney stone had longer gouty duration [(48.7±26.6) months vs. (84.0±30.6) months, P=0.01], higher 24 h urinary oxalate [(20.1±9.6) mg vs. (28.6±20.7) mg, P=0.001] and lower 24 h urinary citrate [(506.3±315.4) mg vs. (355.7±219.6) mg, P=0.001]. Compared with the patients without kidney stone by DECT, the patients with uric acid kidney stone also had longer disease duration [(49.1±28.4) months vs. (108.3±72.2) months, P=0.001], higher 24 h urinary oxalate [(23.6±16.9) mg vs. (28.5±18.8) mg, P < 0.05], lower 24 h urinary citrate [(556.0±316.3) mg vs. (391.7±261.2) mg, P < 0.05], higher serum uric acid [(466.2±134.5) μmol/L vs. (517.2±18.1) μmol/L, P < 0.05] and higher 24 h urinary uric acid [(1 518.1±893.4) mg vs. (1 684.2±812.1) mg, P < 0.05]. Logistic regression analysis showed long gout disease duration (OR=1.229, 95%CI: 1.062-1.522, P < 0.05), high serum uric acid level (OR=1.137, 95%CI: 1.001-1.213, P=0.01), low 24 h urinary citrate (OR=0.821, 95%CI: 0.659-0.952, P=0.01) were all risk factors of kidney stones by ultrasonography. Also, long gout disease duration (OR=1.201, 95%CI: 1.101-1.437, P=0.005), high serum creatine uric level (OR=1.145, 95%CI: 1.001-1.182, P=0.04), low 24 h urinary citrate (OR=0.837, 95%CI: 0.739-0.931, P=0.02) were all risk factors of kidney uric acid stones by DECT. Conclusion: Long disease duration and low 24 h urinary citrate were risk factors for kidney stones.

Key words: Gout, Kidney stone, Citrate, Ultrasonography, Dual-energy computed tomography

CLC Number: 

  • R589.7

Table 1

Clinical characteristics of gout patients with and without kidney stone by ultrasonography"

Items Positive kidney stone by US (n=61) Negative kidney stone by US (n=39) P
Age/years 43.5±9.0 42.8±11.0 0.992
Disease duration/months 84.0±30.6 48.7±26.6 0.01
Gout flare frequency/years 4 (1, 10) 1 (1, 2) 0.05
BMI/(kg/m2) 27.8±3.4 27.2±3.3 0.396
Serum uric acid/(μmol/L) 513.1±128.0 480.4±103.4 0.001
Serum creatinine/(μmol/L) 93.7±14.8 83.4±17.7 0.004
eGFR/(mL/min) 87.4±15.1 97.9±16.6 0.002
hsCRP/(mg/L) 13.8±4.2 12.8±3.2 0.601
Glucose/(mmol/L) 2.4±3.0 3.3±2.6 0.301
TG/(mmol/L) 2.1±1.1 3.2±2.5 0.036
TCHO/(mmol/L) 4.5±1.4 4.6±0.9 0.838
LDL-C/(mmol/L) 2.6±0.9 2.5±0.8 0.549
Urinary oxalic acid/(mg/L) 15.0±8.0 8.3±3.6 0.001
Urinary oxalic acid/(mg/24 h) 28.6±20.7 20.1±9.6 0.006
Urinary citrate/(mg/L) 148.0±86.4 279.2±180.9 0.001
Urinary citrate/(mg/24 h) 355.7±219.6 506.3±315.4 0.006
Urinary calcium/(mmol/L) 2.0±1.3 1.4±1.1 0.037
Urinary uric acid/(mmol/24 h) 1 793.4±863.4 1 235.0±765.0 0.001
Urinary P/(mmol/L) 14.8±6.7 10.4±6.9 0.003
Urinary Mg/(mmol/L) 1.9±0.8 1.6±1.1 0.202
Urinary creatine/(mmol/L) 8.6±3.0 6.4±3.9 0.002

Table 2

Clinical characteristics of gout patients with uric acid kidney stone and without kidney stone by dual-energy CT"

Items Positive uric acid kidney stone by DECT (n=34) Negative kidney stone by DECT (n=30) P
Age/years 44.9±7.4 42.4±10.7 0.475
Disease duration/months 108.3±72.2 49.1±28.4 0.001
Gout flare frequency/years 4 (1, 10) 1 (1, 2) 0.05
BMI/(kg/m2) 27.5±3.6 27.6±3.2 0.933
Serum uric acid/(μmol/L) 517.2±108.1 466.2±134.5 0.001
Serum creatinine/(μmol/L) 93.2±14.7 87.9±17.4 0.132
eGFR/(mL/min) 87.0±14.4 93.8±17.0 0.05
hsCRP/(mg/L) 13.4±2.8 10.1±2.5 0.891
Glucose/(mmol/L) 3.4±2.1 2.2±1.7 0.123
TG/(mmol/L) 1.9±0.8 2.6±2.4 0.089
TCHO/(mmol/L) 4.8±0.6 4.4±1.5 0.204
LDL-C/(mmol/L) 2.7±0.6 2.5±0.9 0.535
Urinary oxalic acid/(mg/L) 15.4±7.2 10.9±7.0 0.003
Urinary oxalic acid/(mg/24 h) 28.5±18.8 23.6±16.9 0.02
Urinary citrate/(mg/L) 183.3±126.2 314.9±193.3 0.001
Urinary citrate/(mg/24 h) 391.7±261.2 556.0±316.3 0.007
Urinary calcium/(mmol/L) 1.9±1.4 1.7±1.3 0.502
Urinary uric acid/(mmol/24 h) 1 684.2±812.1 1 518.1±893.4 0.371
Urinary P/(mmol/L) 13.6±6.2 12.8±7.5 0.583
Urinary Mg/(mmol/L) 1.5±0.5 1.9±1.1 0.083
Urinary creatine/(mmol/L) 8.6±3.1 7.3±3.7 0.077

Figure 1

Receiver operating characteristic curve of 24 h urinary oxalate and urinary citrate for diagnosis of uric acid kidney stone in gout patients"

1 Wallace SL , Robinson H , Masi AT , et al. Preliminary criteria for the classification of the acute arthritis of primary gout[J]. Arthritis Rheum, 1977, 20 (3): 895- 900.
doi: 10.1002/art.1780200320
2 Filippou G , Pascart T , Iagnocco A . Utility of ultrasound and dual energy CT in crystal disease diagnosis and management[J]. Curr Rheumatol Rep, 2020, 22 (5): 15.
doi: 10.1007/s11926-020-0890-1
3 Skolarikos A , Straub M , Knoll T , et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines[J]. Eur Urol, 2015, 67 (4): 750- 763.
doi: 10.1016/j.eururo.2014.10.029
4 Neogi T , Jansen TL , Dalbeth N , et al. 2015 gout classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative[J]. Ann Rheum Dis, 2015, 74 (10): 1789- 1798.
doi: 10.1136/annrheumdis-2015-208237
5 Gutierrez M , Schmidt WA , Thiele RG , et al. International consensus for ultrasound lesions in gout: Results of Delphi process and web-reliability exercise[J]. Rheumatology (Oxford), 2015, 54 (10): 1797- 1805.
doi: 10.1093/rheumatology/kev112
6 范兵, 王霄英, 邱建星, 等. 能谱CT与常规CT对泌尿系结石CT值的相关性分析[J]. CT理论与应用研究, 2016, 25 (4): 403- 408.
doi: 10.15953/j.1004-4140.2016.25.04.03
7 《泌尿外科杂志(电子版)》编辑部. 泌尿系结石诊治指南解读(一)[J]. 泌尿外科杂志(电子版), 2010, 2 (4): 56- 57.
doi: 10.3969/j.issn.1674-7410.2010.04.017
8 Richette P , Doherty M , Pascual E , et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout[J]. Ann Rheum Dis, 2020, 79 (1): 31- 38.
doi: 10.1136/annrheumdis-2019-215315
9 王昱, 陈育青, 张蓓, 等. 原发性痛风患者24 h尿液化学成分分析与尿酸结石形成风险的研究[J]. 中华风湿病学杂志, 2018, 22 (3): 165- 170.
doi: 10.3760/cma.j.issn.1007-7480.2018.03.005
10 Tzelves L , Türk C , Skolarikos A . European Association of Urology urolithiasis guidelines: Where are we going?[J]. Eur Urol Focus, 2021, 7 (1): 34- 38.
doi: 10.1016/j.euf.2020.09.011
11 Pearle MS , Goldfarb DS , Assimos DG , et al. Medical management of kidney stones: AUA guideline[J]. J Urol, 2014, 192 (2): 316- 324.
doi: 10.1016/j.juro.2014.05.006
12 Nestler T , Nestler K , Neisius A , et al. Diagnostic accuracy of third-generation dual-source dual-energy CT: A prospective trial and protocol for clinical implementation[J]. World J Urol, 2019, 37 (4): 735- 741.
doi: 10.1007/s00345-018-2430-4
13 张晓洁, 姜林娣. 痛风患者肾脏结石与关节部位尿酸盐晶体沉积的相关性[J]. 中国临床医学, 2017, 24 (5): 767- 769.
14 Siener R , Glatz S , Nicolay C , et al. Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients[J]. Eur Urol, 2003, 44 (4): 467- 474.
doi: 10.1016/S0302-2838(03)00317-8
15 Mittal A , Tandon S , Singla SK , et al. In vitro inhibition of cal-cium oxalate crystallization and crystal adherence to renal tubular epithelial cells by Terminalia arjuna[J]. Urolithiasis, 2016, 44 (2): 117- 125.
doi: 10.1007/s00240-015-0822-0
16 闫晓煜, 黄志红, 孟胜兰, 等. 24小时尿枸橼酸、草酸定量检测在泌尿系结石诊断中的应用[J]. 标记免疫分析与临床, 2018, 25 (5): 634- 668.
17 Smith LH . Diet and hyperoxaluria in the syndrome of idiopathic calcium oxalate urolithiasis[J]. Am J Kidney Dis, 1991, 17 (4): 370- 375.
doi: 10.1016/S0272-6386(12)80625-1
18 Holmes RP , Goodman HO , Assimos DG . Contribution of dietary oxalate to urinary oxalate excretion[J]. Kidney Int, 2001, 59 (1): 270- 276.
doi: 10.1046/j.1523-1755.2001.00488.x
19 Robijn S , Hoppe B , Vervaet BA , et al. Hyperoxaluria: A gut-kidney axis?[J]. Kidney Int, 2011, 80 (11): 1146- 1158.
doi: 10.1038/ki.2011.287
20 Taylor EN , Curhan GC . Oxalate intake and the risk for nephroli-thiasis[J]. J Am Soc Nephrol, 2007, 18 (7): 2198- 2204.
doi: 10.1681/ASN.2007020219
21 Curhan GC , Taylor EN . 24 h uric acid excretion and the risk of kidney stones[J]. Kidney Int, 2008, 73 (4): 489- 496.
doi: 10.1038/sj.ki.5002708
22 Kok DJ , Papapoulos SE , Bijvoet OL . Crystal agglomeration is a major element in calcium oxalate urinary stone formation[J]. Kidney Int, 1990, 37 (1): 51- 56.
doi: 10.1038/ki.1990.7
23 Mandel EI , Taylor EN , Curhan GC . Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion[J]. Clin J Am Soc Nephrol, 2013, 8 (6): 901- 908.
doi: 10.2215/CJN.07190712
24 Domrongkitchaiporn S , Stitchantrakul W , Kochakarn W . Causes of hypocitraturia in recurrent calcium stone formers: Focusing on urinary potassium excretion[J]. Am J Kidney Dis, 2006, 48 (4): 546- 554.
doi: 10.1053/j.ajkd.2006.06.008
25 Coe FL , Parks JH , Asplin JR . The pathogenesis and treatment of kidney stones[J]. N Engl J Med, 1992, 327 (16): 1141- 1152.
doi: 10.1056/NEJM199210153271607
26 Ettinger B , Tang A , Citron JT , et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi[J]. N Engl J Med, 1986, 315 (22): 1386- 1389.
doi: 10.1056/NEJM198611273152204
27 Ferraro PM , Curhan GC , D'Addessi A , et al. Risk of recurrence of idiopathic calcium kidney stones: Analysis of data from the lite-rature[J]. J Nephrol, 2017, 30 (2): 227- 233.
doi: 10.1007/s40620-016-0283-8
28 Levy FL , Adams-Huet B , Pak CY . Ambulatory evaluation of nephrolithiasis: An update of a 1980 protocol[J]. Am J Med, 1995, 98 (1): 50- 59.
doi: 10.1016/S0002-9343(99)80080-1
[1] Jinfang YUAN, Xinli WANG, Yunpu CUI, Xuemei WANG. Application of urinary luteinizing hormone in the prediction of central precocious puberty in girls [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 788-793.
[2] Yan CHEN,Kuangmeng LI,Kai HONG,Shudong ZHANG,Jianxing CHENG,Zhongjie ZHENG,Wenhao TANG,Lianming ZHAO,Haitao ZHANG,Hui JIANG,Haocheng LIN. Retrospective study on the impact of penile corpus cavernosum injection test on penile vascular function [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 680-686.
[3] Yue WEI,Lan YAO,Xi LU,Jun WANG,Li LIN,Kun-peng LIU. Evaluation of gastric emptying after drinking carbohydrates before cesarean section by gastric ultrasonography [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1082-1087.
[4] Yue WEI,Xi LU,Jing ZHANG,Kun-peng LIU,Yong-jun WANG,Lan YAO. Effect of preoperative carbohydrates intake on the gastric volume and the risk of reflux aspiration in patients positioning in trendelenburg undergoing gynecological laparoscopic procedures [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 893-898.
[5] Hong DONG,Li-min WANG,Zhi-qiang WANG,Yan-qing LIU,Xiao-gang ZHANG,Ming-ming ZHANG,Juan LIU,Zhen-bin LI. Diurnal differences in acute gout attacks: A clinical study of male gout patients [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 915-922.
[6] Qiang FU,Guan-ying GAO,Yan XU,Zhuo-hua LIN,You-jing SUN,Li-gang CUI. Comparative study of ultrasound and magnetic resonance imaging in the diagnosis of asymptomatic anterosuperior acetabular labrum tears [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 665-669.
[7] Yi-lin YE,Heng LIU,Li-ping PAN,Wei-bing CHAI. Periprosthetic gout flare after total knee arthroplasty: A misdiagnostic case report [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 362-365.
[8] Hai-ying XING,Yu-hui CHEN,Ke XU,Dian-dian HUANG,Qing PENG,Ran LIU,Wei SUN,Yi-ning HUANG. Evaluation of carotid atherosclerotic plaques by vascular plaque quantification (VPQ) technology of three-dimensional ultrasonography [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 991-999.
[9] Xiao-wei XIE,Fen LI,Guang-hui LING,Xi XIE,Su-qing XU,Yi-yue CHEN. Development and clinical application of the health education knowledge assessment questionnaire for gout [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 699-704.
[10] PENG Zhe,DING Ya-min,PEI Lin,YAO Hai-hong,ZHANG Xue-wu,TANG Su-mei. Clinical characteristics of crystal deposits in joints and tendons in patients with gout [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1067-1071.
[11] WANG Gui-hong,ZUO Ting,LI Ran,ZUO Zheng-cai. Effect of rebamipide on the acute gouty arthritis in rats induced by monosodium urate crystals [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 716-720.
[12] XIE Yi-fan,WANG Yu,DENG Xue-rong,GENG Yan,JI Lan-lan,ZHANG Zhuo-li. Analysis of risk factors influencing the detection rate of urate crystal by dual energy computed tomography [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 261-265.
[13] YANG Guang-xin,LUAN Jing-yuan,JIA Zi-chang. Radiofrequency obliteration of varicose veins of lower extremity guided by combined venography and ultrasonography [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 332-336.
[14] WANG Yu,DENG Xue-rong,JI Lan-lan,ZHANG Xiao-hui,GENG Yan,ZHANG Zhuo-li. Risk factors and diagnostic value for ultrasound-detected tendon monosodium urate crystal deposition in patients with gout [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 143-149.
[15] Ming-rui WANG,Qi WANG,Hao HU,Jin-hui LAI,Yong-xin HE,Jie XIONG,Xian-hui LIU,Shi-jun LIU,Ke-xin XU,Tao XU. Long-term analysis of safety and efficacy of standard percutaneous nephrolithotomy in patients with solitary kidneys [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 663-666.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd